Charles A. Deignan - Sep 13, 2023 Form 4 Insider Report for Clearside Biomedical, Inc. (CLSD)

Role
Chief Financial Officer
Signature
/s/ Mark Ballantyne, Attorney-in-Fact
Stock symbol
CLSD
Transactions as of
Sep 13, 2023
Transactions value $
$13,636
Form type
4
Date filed
9/13/2023, 06:55 PM
Previous filing
Jan 20, 2023
Next filing
Sep 20, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction CLSD Common Stock Options Exercise $13.6K +34.1K +9.38% $0.40 398K Sep 13, 2023 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CLSD Employee Stock Option (right to buy) Options Exercise $0 -34.1K -100% $0.00* 0 Sep 13, 2023 Common Stock 34.1K $0.40 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Fully vested and exercisable.